The ESG Weekly: Does the 2019 Novel Coronavirus have any place in an ESG conversation? And the EU doubts the use of ESG ratings for the week of February 10.
As the 2019 Novel Coronavirus spreads with worrying speed, we debate the applicability of ESG when it comes to discussing infectious disease and short\u2010term pandemics; and after the EU watchdog says ESG rating firms allow companies to be greenwashed, we discuss what it even means for a company to be considered "green ".